FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to diagnostics of malignant neoplasms by immunologic methods. Laboratory analysis is carried out. In course of laboratory analysis the following immunologic parameters are determined: content of CD10×109/l, CD20×109Al, CD25×l09/l lymphocytes of peripheral blood, functional reserve of cervical mucus neutrophils, level of blood IL-10, and levels of blood IFN-γ and TNF-α of cervical mucus. On the basis of obtained data calculated is parameter, the value of which is used to diagnose carcinoma in situ or cervical intraepithelial neoplasia of III degree.
EFFECT: method makes it possible to perform differential diagnostics of cervical carcinogenesis stages, and thus improve approaches to treatment of women with severe dysplasia and pre-invasive cervical cancer and preserve full reproductive function in said category of patients.
4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2019 |
|
RU2735660C1 |
METHOD OF UPDATING STAGE OF ADVANCED CERVICAL CANCER | 2015 |
|
RU2582979C1 |
METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS OF HIGH ONCOGENIC RISK | 2020 |
|
RU2754494C1 |
METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
METHOD OF COMPLEX THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER | 2013 |
|
RU2560689C2 |
METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER | 2012 |
|
RU2538618C2 |
METHOD FOR PREDICTION OF PERSISTENCE OF ONCOGENIC HUMAN PAPILLOMA VIRUS IN CERVICAL EPITHELIUM | 2012 |
|
RU2520710C1 |
Authors
Dates
2014-02-20—Published
2012-12-10—Filed